Conoce las indicaciones de uso, posología, advertencias y contraindicaciones de cada producto:
- Phillips TG, Slomiany WP, Allison R. Hair Loss: Common Causes and Treatment. Am Fam Physician 2017; 96: 371-78.
- Rigopoulos D, Stamatios G, Ioannides D. Primary scarring alopecias. Curr Probl Dermatol 2015; 47: 76-86.
- Bernárdez C, Molina-Ruiz AM, Requena L. Histologic features of alopecias-part I: nonscarring alopecias. Actas Dermosifiliogr 2015; 106: 158-67.
- Kelly Y, Blanco A, Tosti. Androgenetic alopecia: an update of treatment options. Drugs 2016; 76: 1349-64.
- Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review. Endocrine 2017; 57: 9-17.
- Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol 2018; 31: 11-22.
- Mayo Clinic Staff. Hair Loss. https://www.mayoclinic.org/diseases-conditions/hair-loss/symptoms-causes/syc-20372926?p=11/4
- Fabbrocini G, Cantelli M, Masarà A, et al. Female pattern hair loss: a clinical, pathophysiologic, and therapeutic review. Int J Womens Dermatol 2018; 4: 203-11.
- O’Rahilly, Müller, Carpenter & Swenson. Basic human anatomy. Chapter 4: The skin, hair and nails. WB Saunders Co. Philadelphia (U.S.A.) 2008, 3th ed.
- Palanisamy T. Minoxidil to treat androgenetic alopecia in men and women: what is it & how does it work? Am J Med Medical Sci 2014; 4: 262-5.
- Rossi A, Cantisani C, Melis L, et al. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov 2012; 6: 130-6.
- UpToDate. Minoxidil (topical): Drug information. https://www-uptodate-com.
- Ministerio de Salud y de la Protección Social. Instituto Nacional de Vigilancia de Medicamentos y Alimentos. INVIMA. Minoxidil: Resumen de características de producto (RCP) en medicamentos. http://consultaregistro.invima.gov.co
- Minoxidil MK®-TQFarma. https://www.tqfarma.com/minoxidil-mk
- Medscape. Minoxidil topical (OTC) Patient handout. https://reference.medscape.com/drug/rogaine-minoxidil-topical-343548#912
- WebMD. Minoxidil topical. https://www.webmd.com/drugs/2/drug-3503/minoxidil-topical/details
- Khandpur S, Suman M, Reddy BS. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 2002; 29: 489-98.
- Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011; 65: 1126-34.
- Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47: 377-85.
- Faghihi G, Mozafarpoor S, Asilian A, et al. The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. Indian J Dermatol Venereol Leprol 2018; 84: 547-53.
- RDA. Laser hair removal and minoxidil questions. https://www.realself.com/laser-hair-removal/answers/minoxidil.
- Shin H, Jo SJ, Kim DH, et al. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer 2015; 136: 442-54.
- Lee S, Lee YB, Choe SJ, Lee WS. Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: a systematic review and meta-analysis. Acta Derm Venereol 2019; 99: 12-7.
- Fertig RM, Gamret AC, Darwin E, Gaudi S. Sexual side effects of 5-a-reductase inhibitors finasteride and dutasteride: a comprehensive review. Dermatol Online J 2017; 23: pii: 13030/qt24k8q743.